|
|
Article: Research from K. Fox and co-researchers in the area of heart disease described.
- Article from:
- Heart Disease Weekly
- Article date:
- November 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Angina pectoris is a common manifestation of coronary artery disease (CAD) and there is a need to improve quality of life, by reducing associated symptoms, and prognosis, by preventing acute coronary events. Ivabradine is a new medication which lowers heart rate (HR) by selectively inhibiting the If current without other direct cardiovascular effects," scientists in London, the United Kingdom report (see also Heart Disease).
"The antianginal and anti-ischaemic properties of ivabradine in patients with stable angina have been well demonstrated by placebo-controlled trials. This review analyses the results of two recently reported trials. The ASSOCIATE study ...